Analytic methods for individually randomized group treatment trials and group-randomized trials when subjects belong to multiple groups-Reference-Cited by-同舟云学术

Analytic methods for individually randomized group treatment trials and group-randomized trials when subjects belong to multiple groups

Published:2014-01-08 Issue:13 Volume:33 Page:2178-2190
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statist. Med.

Author:

Andridge Rebecca R.¹,Shoben Abigail B.¹,Muller Keith E.²,Murray David M.³

Affiliation:

1. Division of Biostatistics, College of Public Health; The Ohio State University; Columbus OH 43210 U.S.A.

2. Department of Health Outcomes and Policy, College of Medicine; University of Florida; Gainesville FL 32610 U.S.A.

3. Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health; Rockville MD 20892 U.S.A.

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Reference23 articles.

1. Design and analysis of group-randomized trials in cancer: a review of current practices;Murray;Journal of the National Cancer Institute,2008

2. Individually randomized group treatment trials: a critical appraisal of frequently used design and analytic approaches;Pals;American Journal of Public Health,2008

3. Ignoring the group in group-level hiv/aids intervention trials: a review of reported design and analytic methods;Pals;AIDS,2011

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implementation Research at NHLBI: Methodological and Design Challenges and Lessons Learned from the DECIPHeR Initiative;Ethnicity & Disease;2023-12-01

2. Randomization, design and analysis for interdependency in aging research: no person or mouse is an island;Nature Aging;2022-12-22

3. Accounting for Context in Randomized Trials after Assignment;Prevention Science;2022-09-09

4. Influential methods reports for group-randomized trials and related designs;Clinical Trials;2022-01-06

5. Methodological challenges in pragmatic trials in Alzheimer’s disease and related dementias: Opportunities for improvement;Clinical Trials;2021-11-29